Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 2 Lesion characteristics (n = 26)

From: Stereotactic body radiotherapy for metastatic sarcoma to the lung: adding to the arsenal of local therapy

 

No

%

Median number of treated lesions per patient

Median lesion size, cm

1.1

Range 0.2–3.8

Time from diagnosis to date of SBRT, months

Histology of primary tumor

 Liposarcoma

8

30.8

 Leiomyosarcoma

6

23.1

 Ewing/Ewing-like sarcoma

4

15.4

 Other*

8

30.8

Location of treated lung lesion

 Lung lobe

  Upper lobe

7

26.9

  Lower lobe

12

46.2

  Hilar

2

7.7

  Middle lobe

5

19.2

 Central vs. peripheral

  Central

13

50.0

  Peripheral

13

50.0

  Ultra-central

0

0

Dose (Gy)/fraction

 54/3

10

38.5

 50/5

13

50.0

 50/10

1

3.8

 42/3

1

3.8

 34/1

1

3.8

  1. *Included undifferentiated pleiomorphic sarcoma, myxofibrosarcoma, synovial sarcoma, angiosarcoma, chondrosarcoma
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us